Grant recipients shared their innovative approaches to managing the current HPAI outbreak at the Agricultural Outlook Forum.

Global Veterinary Vaccines Market OverviewThe global veterinary vaccines market is anticipated to grow at a steady compound annual growth rate of approximately 7% over the next five years, reflecting ...

After egg prices soared to multiple record highs in early 2025, the Trump administration launched a series of initiatives to ...

Highly pathogenic avian influenza (HPAI) vaccine trials have started today (Thursday 5 March) in a major step forward in the fight against the disease.

For the second year in a row, highly pathogenic avian influenza (HPAI) has been detected in a commercial farm in Jefferson County.This year's affected premise in the Town ...

When U.S. Health Secretary Robert F. Kennedy Jr. visited Austin Independent School District on Friday to learn more about the district’s school lunch program, parents protested his “very unhealthy” ...

Bioengineered yeast could revolutionize avian flu vaccines with shelf-stable protection. Discover how this innovative ...

Historical Significance: This is the first commercial case in Germany in approximately 18 years.

A technical report issued by partner IntraMont Technologies in late 2025, combined with the final signed report from the ICAR-National Institute of High Security Animal Diseases (NIHSAD), Bhopal, ...

The strain may inadvertently allow processing plants to meet federal standards without reducing foodborne illness.

Livestock vaccine demand surges but requires specialized animal-vaccine manufacturing workflows with distinct production requirements from human vaccines.

Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP and regulatory landscapes.